🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Canada / NCT07659873
Starting soon Not applicable

Advancing Online Psychology Tools for Chronic Pain

NCT07659873 · tracked via the Priya Life Science Canada tracker
Phase
Not applicable
Started
2026-10
Last updated
2026-06-22

Condition(s) studied

FibromyalgiaChronic Pelvic Pain Syndrome

Investigational drug(s) / intervention(s)

Digital psychology intervention (ADOPT-CP)Reminder Emails

Digital psychology intervention (ADOPT-CP): The intervention, Manage My Pain (MMP), is a clinically validated app-based platform that supports individuals with chronic pain in self-managing their symptoms and improving communication and engagement with their care team.

Reminder Emails: Weekly emailed pain self-management resources introduced during the Toronto Academic Pain Medicine Institute (TAPMI) orientation

Study summary

Chronic pain affects more than 20% of Canadians and is associated with significant impacts on physical function, mental health, and quality of life. Despite efforts to improve access to multidisciplinary pain care through centralized referral systems, many patients continue to experience prolonged wait times before receiving treatment.

This study evaluates a self-guided digital psychological intervention designed to support chronic pain self-management during the waiting period for specialized pain care. The intervention was developed through a collaboration between the Transitional Pain Service and ManagingLife and aims to improve access to evidence-based psychological support, enhance self-management skills, and reduce pain-related distress among individuals living with chronic pain.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Must be deemed to have capacity to provide informed consent; 2. Must sign and date the informed consent form; 3. Must state willingness to comply with all study procedures; 4. Must be at least 18 years of age; 5. Must be referred to TAPMI; 6. Must have either fibromyalgia or chronic pelvic pain 7. Must be on the waitlist at TAPMI; 8. Must have access to a device that can connect to the Internet with access to email. Exclusion Criteria: 1. Currently engaged in psychotherapy or engaged in psychotherapy within the last month at the time of enrolment; 2. Unable to read, understand, or communicate in English sufficiently to provide informed consent and complete the study procedures and questionnaires; 3. Has active serious mental illness or psychiatric instability that, in the opinion of the research team, may impair the ability to safely participate in the study or to provide informed consent (e.g., active psychosis, active mania); 4. Has a visual, auditory, or other functional impairment that would prevent independent access to and use of the digital intervention and study procedures on an internet-enabled device.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Women's College Hospital Toronto Ontario

More Women's College Hospital trials in Canada

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07659873 on ClinicalTrials.gov ↗ ← All trials in Canada